Highlights From the American Heart Association’s Scientific Sessions 2022
JAMA Medical News
00:00
Transform Heart Failure and Hypertension - What Did We Learn?
There was also a trial on a small interfering RNA to reduce lipoprotein A. There were two major trials presented at the conference that compared diuretics for heart failure and hypertension. What I think people should also recognize is that the dose could be escalating in both trials to get patients' blood pressures better. The study doses of hydrochlor thiocidoid were 50. We have 85% of the VA patients getting 25. You should start it at 25, but then the guidelines say to titrate up. So we're rating it up.
Transcript
Play full episode
